Peran Probiotik dan Sumbu Usus-Otak (Gut-Brain Axis) dalam Patogenesis dan Penatalaksanaan Depresi: Tinjauan Literatur

Authors

  • Herni Purwantari Poltekkes Kemenkes Malang
  • Nila Authoria Poltekkes Kemenkes Malang

DOI:

https://doi.org/10.55606/jig.v4i1.9433

Keywords:

Depression, Dysbiosis, Gut Microbiota, Gut-Brain Axis, Probiotics

Abstract

Depression is a mental disorder involving biological changes, including an imbalance in the gut microbiota. The gut-brain axis acts as a bidirectional communication system between the gut and the central nervous system through neural, immunological, endocrine, and metabolic pathways. This literature review aims to evaluate the role of the gut-brain axis and probiotics in the pathogenesis and management of depression. The review was conducted narratively using articles retrieved from Google Scholar, PubMed, and ScienceDirect, with 12 studies meeting the inclusion criteria. Results indicate that gut microbiota dysbiosis is associated with increased inflammation, impaired neurotransmitter regulation, changes in microbial metabolites, and dysfunctional gut-brain communication. Several studies have also reported that probiotic supplementation, particularly Lactobacillus and Bifidobacterium, has the potential to improve symptoms of depression and anxiety, improve sleep quality, and influence biological parameters related to the gut-brain axis. However, effectiveness varies depending on the strain, dose, and duration of intervention. Overall, the gut-brain axis plays a crucial role in the pathogenesis of depression, and probiotics have the potential to be used as adjunctive therapy by modulating the gut microbiota. However, large-scale clinical studies with more standardized designs are needed to confirm their effectiveness and mechanisms of action.

Downloads

Download data is not yet available.

References

Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022). The gut microbiome in depression and potential benefit of prebiotics, probiotics, and synbiotics: A systematic review of clinical trials and observational studies. International Journal of Molecular Sciences, 23(4494), 1–27.

Ansari, F., Neshat, M., Pourjafar, H., Jafari, S. M., Samakkhah, S. A., & Mirzakhani, E. (2023). The role of probiotics and prebiotics in modulating the gut-brain axis. Frontiers in Nutrition, 10, Article 1173660. https://doi.org/10.3389/fnut.2023.1173660

Asad, A., Kirk, M., & Gao, M. (2024). Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: Systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 83(7), 1504–1520.

Chen, H.-M., Kuo, P.-H., Hsu, C.-Y., Chiu, Y.-H., Liu, Y.-W., Lu, M.-L., & Chen, C.-H. (2021). Psychophysiological effects of Lactobacillus plantarum PS128. Nutrients, 13(11), 3731. https://doi.org/10.3390/nu13113731

Cheng, J., Hu, H., Ju, Y., Liu, J., & Wang, M. (2024). Gut microbiota-derived short-chain fatty acids and depression: Deep insight into biological mechanisms and potential applications. General Psychiatry, 37, e101374. https://doi.org/10.1136/gpsych-2023-101374

Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., ... Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018

Dacaya, P., Sarapis, K., Hall, R., Yim, K., Resciniti, S., Vinh, A., Truong, T. Q., Pane, M., Biesiekierski, J. R., & Murphy, K. (2025). Exploring neurotransmitter regulation following probiotic supplementation in adults with subthreshold depression: A secondary analysis of a randomized controlled trial. Nutrition, 140, 112891. https://doi.org/10.1016/j.nut.2025.112891

Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews Gastroenterology & Hepatology, 16(8), 461–478. https://doi.org/10.1038/s41575-019-0157-3

Dziedzic, A., Maciak, K., Bliźniak, K., & Gałecka, M. (2024). The power of psychobiotics in depression: A modern approach through the microbiota-gut-brain axis: A literature review. Nutrients, 16(7), 1054. https://doi.org/10.3390/nu16071054

Gambaro, E., Gramaglia, C., Baldon, G., Chirico, E., Martelli, M., Renolfi, A., & Zeppegno, P. (2020). Gut-brain axis: Review of the role of probiotics in anxiety and depressive disorders. Brain and Behavior, 10(11), e01803. https://doi.org/10.1002/brb3.1803

Gawlik-Kotelnicka, O., Margulska, A., Płeska, K., Skowrońska, A., & Strzelecki, D. (2024). Metabolic status influences probiotic efficacy for depression—PRO-DEMET randomized clinical trial results. Nutrients, 16(9), 1389. https://doi.org/10.3390/nu16091389

Godzien, J., Kalaska, B., Rudzki, L., Barbas-Bernardos, C., Świętoń, J., Lopez-Gonzalvez, A., Ostrowska, L., Szulc, A., Waszkiewicz, N., Ciborowski, M., García, A., Kretowski, A., Barbas, C., & Pawlak, D. (2025). Probiotic Lactobacillus plantarum 299v supplementation in patients with major depression in a double-blind, randomized, placebo-controlled trial: A metabolomics study. Journal of Affective Disorders, 368, 180–190. https://doi.org/10.1016/j.jad.2024.09.058

Goel, R., Gupta, B., Satodiya, V. N., Vala, A. U., Dabhi, H., & Mittal, A. (2025). Association of gut microbiome and mental health and effects of probiotics on psychiatric disorders: A meta-analysis and systematic review. Nigerian Medical Journal, 66(1), 13–25.

Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., McGorry, P., Insel, T. R., Weissman, M. M., Chibanda, D., Dowrick, C., Howard, L. M., Hoven, C. W., Knapp, M., Mayberg, H. S., ... Uher, R. (2022). Time for united action on depression: A Lancet–World Psychiatric Association Commission. The Lancet, 399(10328), 957–1022. https://doi.org/10.1016/S0140-6736(21)02141-3

Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2015). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. https://doi.org/10.1038/nrgastro.2014.66

Kelly, J. R., Borre, Y., O’Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P., Stanton, C., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109–118. https://doi.org/10.1016/j.jpsychires.2016.07.019

Kezer, G., Paramithiotis, S., Khwaldia, K., Harahap, I. A., Čagalj, M., Šimat, V., & Esatbeyoglu, T. (2025). A comprehensive overview of the effects of probiotics, prebiotics, and synbiotics on the gut-brain axis. Frontiers in Microbiology, 16, Article 1651965. https://doi.org/10.3389/fmicb.2025.1651965

Kimse, L., Reinis, A., Mikelsone-Jansone, L., Gintere, S., & Krumina, A. (2024). A narrative review of psychobiotics: Probiotics that influence the gut-brain axis. Medicina, 60(4), 601. https://doi.org/10.3390/medicina60040601

Loh, J. S., Mak, W. Q., Kar, L., Tan, S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., & Ong, Y. S. (2024). Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy, 9, 1–53. https://doi.org/10.1038/s41392-024-01743-1

Malhi, G. S., & Mann, J. J. (2018). Depression. The Lancet, 392(10161), 2299–2312. https://doi.org/10.1016/S0140-6736(18)31948-2

Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34. https://doi.org/10.1038/nri.2015.5

Mörkl, S., Narrath, M., Schlotmann, D., Sallmutter, M., Putz, J., & Lang, J. (2025). Multi-species probiotic supplement enhances vagal nerve function: Results of a randomized controlled trial in patients with depression and healthy controls. Gut Microbes, 17(1), 1–20. https://doi.org/10.1080/19490976.2025.2492377

Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016). Major depressive disorder. Nature Reviews Disease Primers, 2, Article 16065. https://doi.org/10.1038/nrdp.2016.65

Radford-Smith, D. E., & Anthony, D. C. (2023). Prebiotic and probiotic modulation of the microbiota-gut-brain axis in depression. Nutrients, 15(8), 1880. https://doi.org/10.3390/nu15081880

Rahmannia, M., Poudineh, M., Mirzaei, R., Aalipour, M. A., Hashem, A., Bonjar, S., Goudarzi, M., Kheradmand, A., Aslani, H. R., Sadeghian, M., Nasiri, M. J., & Sechi, L. A. (2024). Strain-specific effects of probiotics on depression and anxiety: A meta-analysis. Gut Pathogens, 16(46), 1–10. https://doi.org/10.1186/s13099-024-00634-4

Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Puga-Olguín, A., Soto, M. E., Medina, A. Y., Muñoz-Carillo, J. L., Rodríguez-Landa, J. F., & Soria-Fregozo, C. (2025). Gut-brain axis in mood disorders: A narrative review of neurobiological insights and probiotic interventions. Biomedicines, 13(8), 1831. https://doi.org/10.3390/biomedicines13081831

Ruiz-Gonzalez, C., Cardona, D., Ruzafa, L. R., & Arrastia, M. R. (2025). Cognitive and emotional effect of a multi-species probiotic containing Lactobacillus rhamnosus and Bifidobacterium lactis in healthy older adults: A double-blind randomized placebo-controlled crossover trial. Probiotics and Antimicrobial Proteins, 17, 3525–3537. https://doi.org/10.1007/s12602-024-10315-2

Schaub, A., Schneider, E., Vazquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., & Doll, J. P. K. (2022). Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: A randomized controlled trial. Translational Psychiatry, 12(1), 227. https://doi.org/10.1038/s41398-022-01977-z

Strodl, E., Bambling, M., Cramb, S., Vitetta, L., Parnam, S., & Ritchie, G. (2024). Probiotics and magnesium orotate for the treatment of major depressive disorder: A randomised double-blind controlled trial. Scientific Reports, 14, Article 71093. https://doi.org/10.1038/s41598-024-71093-z

Veibäck, G. S., Lindahl, J., Suneson, K., Kjellberg, A., Falkén, F., Sjöberg, K., & Lindqvist, D. (2025). Add-on probiotics for inflammatory depression: A double-blind randomized placebo-controlled trial. Brain, Behavior, and Immunity, 129, 348–358. https://doi.org/10.1016/j.bbi.2025.06.002

Wallace, C. J. K., & Milev, R. V. (2021). The efficacy, safety, and tolerability of probiotics on depression: Clinical results from an open-label pilot study. Frontiers in Psychiatry, 12, Article 618279. https://doi.org/10.3389/fpsyt.2021.618279

World Health Organization. (2025). Mental disorders. https://www.who.int/news-room/fact-sheets/detail/mental-disorders

Zhang, X., Chen, S., Zhang, M., Ren, F., Ren, Y., Li, Y., Liu, N., Zhang, Y., Zhang, Q., & Wang, R. (2021). Effects of fermented milk containing Lacticaseibacillus paracasei strain Shirota on constipation in patients with depression: A randomized, double-blind, placebo-controlled trial. Nutrients, 13(7), 2238. https://doi.org/10.3390/nu13072238

Zhu, R., Fang, Y., Li, H., Liu, Y., Wei, J., Li, S., & Chen, T. (2023). Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test-anxious college students via modulating the gut microbiota and its metabolism. Frontiers in Immunology, 14, Article 1158137. https://doi.org/10.3389/fimmu.2023.1158137

Zhu, Z., Cheng, Y., Liu, X., & Xu, X. (2025). The microbiota-gut-brain axis in depression: Unraveling the relationships and therapeutic opportunities. Frontiers in Immunology, 16, Article 1644160. https://doi.org/10.3389/fimmu.2025.1644160

Downloads

Published

2026-01-31

How to Cite

Herni Purwantari, & Nila Authoria. (2026). Peran Probiotik dan Sumbu Usus-Otak (Gut-Brain Axis) dalam Patogenesis dan Penatalaksanaan Depresi: Tinjauan Literatur . Jurnal Ilmu Kesehatan Dan Gizi, 4(1), 129–142. https://doi.org/10.55606/jig.v4i1.9433